Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy.

Source:http://linkedlifedata.com/resource/pubmed/id/20185047

J. Am. Coll. Cardiol. 2010 Mar 2 55 9 926-7

Download in:

View as

General Info

PMID
20185047